Bonness Enterprises Inc holds a focused book of 37 reported positions worth $310.1M as of Q2 2026 (disclosed Jul 9, 2026, a ~9-day 13F lag). This quarter they trimmed Progressive Corp. Their largest long position is Progressive Corp at 36% of the reported non-option book. Cloning the disclosed picks since 2025 would be +18% (+10.5%/yr). That is a simulation of the disclosed long book, not audited returns.
The reported book (valued from quarter-end) returned +19.4%, a 1.5-point gap that is the cost of the ~9-day 13F disclosure lag a real follower can't avoid.
Growth of $10,000 cloning Bonness Enterprises Inc's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~9 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: focused book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
100% mapped to company sectors
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
Other tracked managers holding the same core names as Bonness Enterprises Inc
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| Independent Investors Inc | 20 / 37 | $390.5M |
| H&H International Investment, LLC | 3 / 37 | $12.7B |
| Ardent Capital Management, Inc. | 9 / 37 | $150.4M |
| 9823 Capital, L.P. | 3 / 37 | $91.0M |
| Daniel Investment Group, Inc. | 4 / 37 | $99.9M |
| Josh Arnold Investment Consultant, LLC | 4 / 37 | $92.7M |
| Armstrong Henry H Associates Inc | 16 / 37 | $596.7M |
| Greenleaf Trust | 36 / 37 | $5.7B |
Ranked by the share of each fund's own book sitting in the names it shares with Bonness Enterprises Inc: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Progressive Corp COM | $111.7M | 511.5K | 36.0% | ▼−0.2% Reduced · −1K sh | |
| 2 | Stryker Corporation COM | $19.2M | 61.1K | 6.2% | ▼−4.2% Reduced · −3K sh | |
| 3 | Applied Matls Inc COM | $15.7M | 21.8K | 5.1% | ▼−12% Reduced · −3K sh | |
| 4 | Apple Inc COM | $14.2M | 49.1K | 4.6% | —Held | |
| 5 | Microsoft Corp COM | $14.2M | 38.0K | 4.6% | ▼−1.3% Reduced · −500 sh | |
| 6 | Corning Inc COM | $13.5M | 52.8K | 4.3% | ▼−21% Reduced · −14K sh | |
| 7 | Intel Corp COM | $11.4M | 81.8K | 3.7% | ▼−15% Reduced · −15K sh | |
| 8 | Cisco Sys Inc COM | $10.4M | 88.4K | 3.3% | ▼−7.9% Reduced · −8K sh | |
| 9 | Johnson & Johnson COM | $9.8M | 38.5K | 3.2% | —Held | |
| 10 | Abbvie Inc COM | $9.3M | 36.9K | 3.0% | —Held | |
| 11 | Merck & Co Inc COM | $8.9M | 69.5K | 2.9% | —Held | |
| 12 | International Business Machs COM | $8.3M | 29.6K | 2.7% | —Held | |
| 13 | Emerson Elec Co COM | $6.2M | 43.0K | 2.0% | —Held | |
| 14 | Nucor Corp COM | $5.2M | 23.4K | 1.7% | ▼−14% Reduced · −4K sh | |
| 15 | Thermo Fisher Scientific Inc COM | $4.4M | 8.9K | 1.4% | —Held | |
| 16 | Pfizer Inc COM | $4.3M | 178.3K | 1.4% | ▲+0.5% Added · +800 sh | |
| 17 | Marsh & McLennan Cos Inc COM | $4.2M | 25.3K | 1.4% | —Held | |
| 18 | Bristol-Myers Squibb Co COM | $3.1M | 54.3K | 1.0% | —Held | |
| 19 | Abbott Laboratories COM | $3.0M | 32.7K | 1.0% | —Held | |
| 20 | Hewlett Packard Enterprise C COM | $2.6M | 57.1K | 0.8% | —Held | |
| 21 | ING Groep N.V. SPONSORED ADR | $2.6M | 82.0K | 0.8% | —Held | |
| 22 | United Parcel Svcs Inc CL B | $2.5M | 23.4K | 0.8% | ▲+0.9% Added · +200 sh | |
| 23 | Procter & Gamble Co COM | $2.4M | 16.4K | 0.8% | —Held | |
| 24 | Agilent Technologies Inc COM | $2.4M | 17.9K | 0.8% | —Held | |
| 25 | Koninklijke Philips N V NY REGIS SHS NEW | $2.4M | 87.0K | 0.8% | —Held | |
| 26 | Coca Cola Co COM | $2.3M | 28.1K | 0.7% | —Held | |
| 27 | Northern TR Corp COM | $2.2M | 12.7K | 0.7% | —Held | |
| 28 | GSK PLC SPONSORED ADR | $2.2M | 41.5K | 0.7% | —Held | |
| 29 | Verizon Communications Inc COM | $2.1M | 50.4K | 0.7% | —Held | |
| 30 | Exxon Mobil Corp COM | $1.9M | 14.2K | 0.6% | —Held | |
| 31 | AT&T Inc COM | $1.8M | 89.2K | 0.6% | —Held | |
| 32 | Gen Digital Inc COM | $1.6M | 62.5K | 0.5% | ▲+21% Added · +11K sh | |
| 33 | HP Inc COM | $1.3M | 57.6K | 0.4% | —Held | |
| 34 | Ge Aerospace COM NEW | $928K | 2.5K | 0.3% | —Held | |
| 35 | Ge Vernova Inc COM | $728K | 620 | 0.2% | —Held | |
| 36 | Berkshire Hathaway Inc Del CL B NEW | $676K | 1.4K | 0.2% | —Held | |
| 37 | Oracle Corp COM | $407K | 2.8K | 0.1% | —Held |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1105471/holdings"
Use Arkolith to show BONNESS ENTERPRISES INC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter. Raw filing totals can include option notional.
| Quarter | As of | Filed | Lag | Positions | Value | Form |
|---|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 9, 2026 | 9d | 56 | $310.1M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 27, 2026 | 27d | 58 | $273.2M | 13F-HR/A |
| Q4 2025 | Dec 31, 2025 | Jan 14, 2026 | 14d | 58 | $289.7M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 15, 2025 | 15d | 58 | $304.8M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 16, 2025 | 16d | 58 | $305.4M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 11, 2025 | 11d | 57 | $306.5M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 16, 2025 | 16d | 58 | $285.0M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.